|
¸ÞµðÈúº´¿ø |
¾à»ç
¼¿ï ¾çõ±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°ø°³Ã¤¿ë |
1³â¡è |
ä¿ë½Ã |
04.28 |
|
|
¸ÓÅ©(ÁÖ) |
Á¦Ç° °ü¸®ÀÚ N&I(HSL)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
03.18 |
|
|
Çѽº¹ÙÀÌ¿À¸Þµå(ÁÖ) |
º»»ç ÀÎÇã°¡ÆÀ °æ·ÂÁ÷ ¼ö½Ãä¿ë
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
12.18 |
|
|
À̳뿡ÀÌÄ¡¾ËÄÁ¼³Æà |
[¿Ü±¹°èÁ¦¾àȸ»ç] Medical Doctor ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
06.15 |
|
|
¸Þµð¿þÀÌ |
¿µ¾÷Áö¿ª´ã´çÀÚ¸¦ ¸ð½Ê´Ï´Ù.
¼¿ï ÀüÁö¿ª, ÀÎõ ÀüÁö¿ª | ´ëÇÐ(2~3³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
08.11 |
|
|
¢ß¿ÀÅ亹ÄÚ¸®¾ÆÇコÄɾî |
¢ß¿ÀÅ亹ÄÚ¸®¾ÆÇコÄɾî - °í°´ÀüÈ»ó´ã ¸®¼Ä¡ (TM À¯°æÇè
¼¿ï °³²±¸ | Çз¹«°ü |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
03.31 |
|
|
(ÁÖ)¼¼Á¾¾¾¾Ë¿À |
¼¼Á¾CRO - RA (Regulatory Affairs) ½ÅÀÔ ¹× °æ·ÂÀÚ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
07.23 |
|
|
Æ÷Ƽ½ºÆÄÆ®³Ê½º |
¿Ü±¹°è Á¦¾à»ç Medical Advisor(»êºÎÀΰúÀÇ»ç) Ãʺù
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
1³â¡è |
ä¿ë½Ã |
07.16 |
|
|
Á¦À̾¾¹ÙÀÌ¿ÀÆĸ¶ |
Á¦¾àº´¿ø¿µ¾÷ °æ·ÂÁ÷ »ç¿ø ¸ðÁý
Àü±¹ Àü±¹ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
12.06 |
|
|
(ÁÖ)¹ÙÀÌ¿À·Îº¸Æ½½º |
ÀÇ·á±â±â º¸Çè±Þ¿©/Çã°¡ ´ã´ç Á÷¿ø ¸ðÁý
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
1³â¡è |
ä¿ë½Ã |
08.09 |
|
|
(ÁÖ)Ç㽺Äɾî |
GIP / RA ºÐ¾ß ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) ÀçÇÐ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
1³â¡è |
»ó½Ãä¿ë |
08.26 |
|
|
PharmaNet |
[Global CRO PharmaNet] °æ·Â CRA ±¸ÀÎ
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.30 |
|
|
Çãºêºê·¹ÀÎ |
À¯¸í »óÀå Á¦Á¶»ç - °ü¸®¾à»çÃʺù
°æ±â ¾È»ê½Ã ´Ü¿ø±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
»ý»ê/»ý»ê°ü¸® |
1³â¡è |
ä¿ë½Ã |
09.30 |
|
|
À̳뿡ÀÌÄ¡¾ËÄÁ¼³Æà |
CRA/CL(CRM,PM)/RA/MA/ML ÃʺùÇÕ´Ï´Ù.
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
11.03 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆÄ·º¼¿ ÄÚ¸®¾Æ- CRA/ Dedicated CRA
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.08 |
|